SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,006,721 | -77.7% | 217,905 | -61.1% | 0.00% | -80.0% |
| Q4 2022 | $4,524,113 | +55.7% | 559,915 | +6.9% | 0.01% | +66.7% |
| Q3 2022 | $2,906,000 | -2.9% | 523,621 | -8.8% | 0.01% | 0.0% |
| Q2 2022 | $2,992,000 | +40.1% | 574,239 | +399.8% | 0.01% | -40.0% |
| Q2 2021 | $2,136,000 | -70.7% | 114,895 | -64.1% | 0.01% | -69.7% |
| Q1 2021 | $7,294,000 | +7.3% | 320,444 | +2.3% | 0.03% | -10.8% |
| Q4 2020 | $6,798,000 | – | 313,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |